This inventor holds 4 USPTO granted patents. Top assignees: Spofa United Pharmaceutical Works, Spofa, Pharmaceutical Works, Spofa, United Pharmeceutical Works. Active years: 1976-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1982
Title: Marie Auskova: Innovator in Pharmaceutical Chemistry
Introduction
Marie Auskova is a prominent inventor based in Prague, Czech Republic. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 4 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Among her latest patents, Marie has developed alkyl cyanomethyl ergoline-I derivatives and salts thereof. This innovative procedure describes the preparation of a new group of alkyl cyanomethyl ergoline-I derivatives and pharmaceutically acceptable salts. The compounds are characterized as D-6-alkyl-8-cyanomethylergoline-I derivatives, where R represents an alkyl group of 2-4 carbon atoms. Additionally, she has created a process for the preparation of novel 6-substituted derivatives of D-8-ergolin-I-ylacetamide, which exhibit superior antilactation and antinidation characteristics compared to prior art compounds.
Career Highlights
Marie has worked with notable companies in the pharmaceutical industry, including Spofa United Pharmaceutical Works and Spofa. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in drug development.
Collaborations
Throughout her career, Marie has collaborated with esteemed colleagues such as Miroslav Semonsky and Miroslav Seda. These partnerships have fostered a productive environment for innovation and research.
Conclusion
Marie Auskova stands out as a dedicated inventor in the pharmaceutical field, with a focus on developing innovative compounds that address critical health issues. Her contributions continue to impact the industry positively, showcasing her commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile